Kim, S., & Kim, D. (2015). Comment on “Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors”. Haematologica.
シカゴスタイル引用形Kim, Sung-Hyun, , Dong-Wook Kim. "Comment On “Efficacy and Safety of Radotinib in Chronic Phase Chronic Myeloid Leukemia Patients With Resistance or Intolerance to BCR-ABL1 Tyrosine Kinase Inhibitors”." Haematologica 2015.
MLA引用形式Kim, Sung-Hyun, , Dong-Wook Kim. "Comment On “Efficacy and Safety of Radotinib in Chronic Phase Chronic Myeloid Leukemia Patients With Resistance or Intolerance to BCR-ABL1 Tyrosine Kinase Inhibitors”." Haematologica 2015.
警告: この引用は必ずしも正確ではありません.